Burstable Health Team
Health In-Focus
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
2653 articles
Articles
SouthernMED Pediatrics Acquires Tri-County Pediatrics to Expand Healthcare Access in Northern South Carolina
SouthernMED Pediatrics has acquired Tri-County Pediatrics, expanding pediatric healthcare access in northern South Carolina's Tri-County region effective December 3, 2025. The acquisition integrates two established offices in Rock Hill and York into SouthernMED's growing statewide network, strengthening care availability in...
December 4, 2025Read the full article
MelGeek Centauri Series Merges Gaming Performance with Enthusiast Customization Through Advanced Magnetic Technology
The MelGeek Centauri series represents a significant development in the keyboard market by attempting to bridge the traditional divide between gaming-focused peripherals and enthusiast custom keyboards. As magnetic Hall Effect keyboards evolve from specialized gaming tools into versatile lifestyle products, users increasing...
December 4, 2025Read the full article
Intravenous Everolimus Formulation Shows Reduced Gastrointestinal Exposure in New Pharmacokinetic Data
New pharmacokinetic data from Oncotelic Therapeutics, Inc. reveals that its intravenous Deciparticle formulation of everolimus, designated Sapu003, significantly reduces gastrointestinal drug accumulation when compared to oral administration of the same medication. The findings demonstrate that oral dosing results in extrem...
December 3, 2025Read the full article
Soligenix's HyBryte Development Highlights Dual Challenge of Rare Disease Treatment and Policy Support
The growing burden of rare diseases affecting more than 30 million Americans has created an urgent need for new therapies, placing companies like Soligenix Inc. at the forefront of both medical innovation and national health policy discussions. A recent editorial titled "Chronic Rare Diseases in an Aging America: Why HyBryt...
December 3, 2025Read the full article
Nature Review Highlights Cardiovascular Crisis in Dialysis Patients, Sigyn's CardioDialysis Offers Non-Pharmacological Approach
A recent review article in Nature reinforces the urgent need to address cardiovascular disease in end-stage renal disease patients, reporting that ESRD dialysis patients face up to a 20-fold greater risk of death from cardiovascular disease compared to the general population. The article, accessible at https://www.nature.co...
December 3, 2025Read the full article
SouthernMED Pediatrics Expands Services in North Augusta Through NiteOwl Integration
SouthernMED Pediatrics has announced the integration of NiteOwl Pediatric Urgent Care into its network, creating SouthernMED Pediatrics + NiteOwl Extended Hours in North Augusta. The practice, located at 616 Edgefield Road, Suite 180, will continue providing after-hours pediatric care through December before expanding its s...
December 3, 2025Read the full article
Florida CCHR Demands Total Ban on Electroconvulsive Therapy Following International Survey Revealing Widespread Harm
The Florida chapter of the Citizens Commission on Human Rights is intensifying its call for a total ban on electroconvulsive therapy following the release of a landmark international survey documenting widespread patient harm and systematic violations of informed consent. Psychiatrists prescribe ECT for approximately 100,00...
December 3, 2025Read the full article
Bryan Therapeutics Warns of Counterfeit Nitric Oxide Products, Urges Consumer Caution
Bryan Therapeutics has issued a warning about counterfeit versions of its N1o1 and NO2U nitric oxide products, citing significant safety concerns for consumers. The company's CEO, Dr. Nathan S. Bryan, stated that products appearing to originate from Bryan Therapeutics but sold by unauthorized sellers may be stolen goods or ...
December 2, 2025Read the full article
Entrepreneurs Transform Personal Adversity into Business Success Through Resilience
Entrepreneur has published a new article examining how three women rebuilt their lives and careers after major personal disruptions, transforming loss into business advantages. The piece profiles Lindsay O'Neill-O'Keefe, Pam Gold, and Jenna Zwagil, whose experiences demonstrate resilience as a competitive edge for career re...
December 2, 2025Read the full article
Neurothera Labs Seeks Quantum Computing Acquisition to Revolutionize Clinical Analytics
Neurothera Labs Inc., a clinical-stage biotech company and majority-owned subsidiary of SciSparc Ltd., announced it has entered into a non-binding term sheet to acquire a 55% equity interest in a quantum computing bio data company focused on quantum-enabled clinical analytics. The acquisition would involve Neurothera issuin...
December 2, 2025Read the full article
HealthLynked Appoints Insurance and Benefits Experts to Board Amid Expansion Push
HealthLynked Corp. (OTCQB: HLYK) has appointed Chris G. Pulos of Marsh McLennan Agency and Jason Bishara of NSI Insurance Group to its Board of Directors. The company stated these appointments bring decades of experience in employer benefits, payer strategy, insurance and risk management to support its expansion efforts. Fo...
December 2, 2025Read the full article
HealthLynked Appoints Insurance and Risk Management Experts to Board Ahead of Nasdaq Listing
HealthLynked Corp. has appointed Chris G. Pulos of Marsh McLennan Agency and Jason Bishara of NSI Insurance Group to its Board of Directors. The company stated these appointments bring decades of experience in employer benefits, payer strategy, insurance and risk management to support its expansion efforts with insurers, em...
December 2, 2025Read the full article
Sapu Nano's Deciparticle Platform Advances Hydrophobic Drug Delivery with Versatile Nanoparticle Formulation
New data presented at the 2025 San Antonio Breast Cancer Symposium indicates that Sapu Nano's Deciparticle nanomedicine platform can consistently formulate structurally diverse hydrophobic therapeutics into sub-20 nanometer nanoparticles suitable for intravenous delivery. The platform successfully formulated macrolide mTOR ...
December 2, 2025Read the full article
Electric Vehicles Outsell Gasoline and Diesel Models in Europe for First Time
The European automobile market demonstrated notable resilience in October with a 4.9% increase in new vehicle registrations, according to data from the European Automobile Manufacturers’ Association (ACEA). This growth represents a pivotal moment for the industry, which has faced numerous challenges throughout the year, inc...
December 2, 2025Read the full article
Nevada Organic Phosphate Advances North America's Only Large-Scale Organic Sedimentary Phosphate Project
Nevada Organic Phosphate Inc. is advancing what it describes as the only known large-scale organic sedimentary phosphate project in North America, positioning itself to serve the expanding organic agricultural market. The company's Murdock Mountain mineralization is uniquely pure, requiring no beneficiation and meeting the ...
December 2, 2025Read the full article
U.S. Healthcare Crisis Reaches Critical Point Amid Soaring Costs and Political Turmoil
The United States healthcare system faces mounting pressure as insurance costs continue to soar amid a high cost of living, creating an urgent need for systemic reform. The issue recently reached a critical point, contributing to a federal government shutdown that was only resolved with a promise to vote on expiring healthc...
December 2, 2025Read the full article
Soligenix Advances Rare Disease Treatment Amid Growing Healthcare Challenge for Aging Population
The growing burden of chronic rare diseases among America's aging population represents an urgent healthcare challenge, with more than 30 million Americans affected by rare diseases according to the National Institutes of Health. Most of these conditions lack FDA-approved treatments, creating significant vulnerabilities for...
December 2, 2025Read the full article
ABVC BioPharma Highlights Plant-Based ADHD Treatment as Alternative to Conventional Therapies Amid Growing Concerns
ABVC BioPharma has addressed growing public concern about attention-deficit/hyperactivity disorder treatment in the United States, emphasizing the safety-focused approach of its plant-based drug candidate ABV-1505. Recent media reports have highlighted an increasing trend of psychiatric polypharmacy, where individuals who b...
December 2, 2025Read the full article
Lifespring Chiropractic Earns Fourth Best Chiropractor Award in Austin with Nervous System Focus
Lifespring Chiropractic has been voted Best Chiropractor in Austin for 2025—its most meaningful win yet. With a deepened nervous-system focus, the clinic is helping Austinites experience lasting improvements far beyond short-term pain relief.
December 2, 2025Read the full article
CTT Pharma Advances Micelle Thin-Film Technology Toward 2026 Commercialization
CTT Pharma CEO Ryan Khouri detailed the company's strategy to progress its patented micelle thin-film technology toward manufacturing and commercialization in a shareholder letter. The company is preparing to file an S-1 registration statement to access funding from an equity line and transition to an SEC reporting company,...
December 2, 2025Read the full article
HeartBeam Pursues Regulatory Path After FDA Decision on ECG Software
HeartBeam has detailed its regulatory strategy after receiving a Not Substantially Equivalent decision from the U.S. Food and Drug Administration for its 510(k) submission covering its 12-lead ECG Synthesis Software. The medical technology company, which develops personalized cardiac-care insights, has been in active discus...
December 1, 2025Read the full article